EP0629133 - PEPTIDE-METAL ION PHARMACEUTICAL APPLICATIONS [Right-click to bookmark this link] | |||
Former [1994/51] | PROTEIN- AND PEPTIDE-METAL ION PHARMACEUTICAL APPLICATIONS | ||
[1999/33] | Status | Patent revoked Status updated on 30.07.2010 Database last updated on 25.04.2018 | Most recent event Tooltip | 30.07.2010 | New entry: Despatch of communication that patent is revoked | 30.07.2010 | Revocation of patent | published on 01.09.2010 [2010/35] | Applicant(s) | For all designated states Rhomed, Incorporated 4261 Balloon Park Road, N.E. Albuquerque New Mexico 87109 / US | [N/P] |
Former [1994/51] | For all designated states Rhomed, Incorporated 4261 Balloon Park Road, N.E. Albuquerque, New Mexico 87109 / US | Inventor(s) | 01 /
RHODES, Buck, A. 1104 Stanford Drive, Northeast Albuquerque, NM 87106 / US | 02 /
ZAMORA, Paul, O. 1514 Vassar, Northeast Albuquerque, NM 87106 / US | [1994/51] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
Former [2002/15] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | ||
Former [1998/45] | Braun, André BRAUN & PARTNER Patent-, Marken-, Rechtsanwälte Reussstrasse 22 4054 Basel / CH | ||
Former [1998/17] | Warden, John Christopher Abbots Piece Church Lane Islip GB-Oxfordshire OX5 2TA / GB | ||
Former [1997/46] | Braun, André BRAUN & PARTNER Patent-, Marken-, Rechtsanwälte Reussstrasse 22 4054 Basel / CH | ||
Former [1996/49] | Martin, Björn A. Kerr AG Finkelerweg 44 CH-4144 Arlesheim / CH | ||
Former [1994/51] | Kerr, Andrew A.KERR AG, Postfach 444, Finkelerweg 44 CH-4144 Arlesheim / CH | Application number, filing date | 93902846.0 | 31.12.1992 | [1994/51] | WO1992US11334 | Priority number, date | US19920816476 | 03.01.1992 Original published format: US 816476 | US19920816477 | 03.01.1992 Original published format: US 816477 | US19920840077 | 20.02.1992 Original published format: US 840077 | US19920998820 | 30.12.1992 Original published format: US 998820 | US19920998910 | 30.12.1992 Original published format: US 998910 | [1994/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9312819 | Date: | 08.07.1993 | Language: | EN | [1993/16] | Type: | A1 Application with search report | No.: | EP0629133 | Date: | 21.12.1994 | Language: | EN | The application has been published by WIPO in one of the EPO official languages on 08.07.1993 | [1994/51] | Type: | B1 Patent specification | No.: | EP0629133 | Date: | 29.11.2000 | Language: | EN | [2000/48] | Search report(s) | International search report - published on: | US | 08.07.1993 | (Supplementary) European search report - dispatched on: | EP | 15.12.1994 | Classification | International: | A61K51/00 | [2006/38] |
Former International [1999/33] | A61K51/08, C07K7/08 | ||
Former International [1994/51] | A61K49/02, A61K43/00, C07K7/00, C07K15/28 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, IT, LI, NL, SE [1994/51] | Title | German: | PHARMAZEUTISCHE ANWENDUNGEN AUF DER BASIS VON PEPTID-METALL-IONEN | [1999/33] | English: | PEPTIDE-METAL ION PHARMACEUTICAL APPLICATIONS | [1999/33] | French: | APPLICATIONS PHARMACEUTIQUES A BASE D'IONS METALLIQUES ET PEPTIDES | [1999/33] |
Former [1994/51] | PHARMAZEUTISCHE ANWENDUNGEN AUF DER BASIS VON PROTEIN- UND PEPTID-METALL-IONEN | ||
Former [1994/51] | PROTEIN- AND PEPTIDE-METAL ION PHARMACEUTICAL APPLICATIONS | ||
Former [1994/51] | APPLICATIONS PHARMACEUTIQUES A BASE D'IONS METALLIQUES-PROTEINES ET PEPTIDES | Entry into regional phase | 29.07.1994 | National basic fee paid | 29.07.1994 | Search fee paid | 29.07.1994 | Designation fee(s) paid | 29.07.1994 | Examination fee paid | Examination procedure | 30.07.1993 | Request for preliminary examination filed International Preliminary Examining Authority: DE | 29.07.1994 | Examination requested [1994/51] | 28.12.1995 | Despatch of a communication from the examining division (Time limit: M04) | 29.03.1996 | Reply to a communication from the examining division | 08.06.1998 | Despatch of a communication from the examining division (Time limit: M06) | 05.10.1998 | Reply to a communication from the examining division | 10.12.1998 | Despatch of a communication from the examining division (Time limit: M02) | 03.02.1999 | Reply to a communication from the examining division | 09.12.1999 | Despatch of communication of intention to grant (Approval: Yes) | 17.05.2000 | Communication of intention to grant the patent | 18.08.2000 | Fee for grant paid | 18.08.2000 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
28.08.2001
12.09.2001
ADMISSIBLE ANTISOMA PLC West Africa House, Hanger Lane, Ealing LONDON, W5 3QR / GB Opponent's representative Thomas, Philip John Duval, et al Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | 02
29.08.2001
12.09.2001
ADMISSIBLE Schering AG Müllerstrasse 178 13342 Berlin / DE Opponent's representative Dörries, Hans Ulrich, et al df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [N/P] |
Former [2008/47] | |||
Opponent(s) | 01
28.08.2001
12.09.2001
ADMISSIBLE ANTISOMA PLC West Africa House, Hanger Lane, Ealing LONDON, W5 3QR / GB Opponent's representative Thomas, Philip John Duval, et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
02
29.08.2001
12.09.2001
ADMISSIBLE Schering AG Müllerstrasse 178 13342 Berlin / DE Opponent's representative Dörries, Hans Ulrich, et al df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | |||
Former [2008/33] | |||
Opponent(s) | 01
28.08.2001
12.09.2001
ADMISSIBLE ANTISOMA PLC West Africa House, Hanger Lane, Ealing LONDON, W5 3QR / GB Opponent's representative Thomas, Philip John Duval, et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
02
29.08.2001
12.09.2001
ADMISSIBLE Schering AG Müllerstrasse 178 13342 Berlin / DE Opponent's representative Dörries, Hans Ulrich, Dr., et al Dörries Frank-Molnia Pohlman Postfach 22 16 61 80506 München / DE | |||
Former [2005/03] | |||
Opponent(s) | 01
28.08.2001
12.09.2001
ADMISSIBLE ANTISOMA PLC West Africa House, Hanger Lane, Ealing LONDON, W5 3QR / GB Opponent's representative Thomas, Philip John Duval, et al Eric Potter Clarkson Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB | ||
02
29.08.2001
12.09.2001
ADMISSIBLE Schering AG Müllerstrasse 178 13342 Berlin / DE Opponent's representative Dörries, Hans Ulrich, Dr., et al Dörries Frank-Molnia Pohlman Postfach 22 16 61 80506 München / DE | |||
Former [2001/44] | |||
Opponent(s) | 01
28.08.2001
12.09.2001
ADMISSIBLE ANTISOMA PLC West Africa House, Hanger Lane, Ealing LONDON, W5 3QR / GB Opponent's representative Thomas, Philip John Duval, et al Eric Potter Clarkson Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB | ||
02
29.08.2001
12.09.2001
ADMISSIBLE Schering AG Müllerstrasse 178 13342 Berlin / DE Opponent's representative Dörries, Hans Ulrich (DE), et al Dörries Frank-Molnia Pohlman Triftstrasse 13 D-80538 München / DE | 08.10.2001 | Invitation to proprietor to file observations on the notice of opposition | 18.11.2002 | Reply of patent proprietor to notice(s) of opposition | 10.04.2003 | Despatch of a communication from the opposition division (Time limit: M06) | 20.10.2003 | Reply to a communication from the opposition division | 03.11.2005 | Date of oral proceedings | 25.04.2006 | Despatch of interlocutory decision in opposition | 25.04.2006 | Despatch of minutes of oral proceedings | 28.11.2008 | Legal effect of revocation of patent [2010/35] | 28.11.2008 | Despatch of communication that the patent will be revoked | Appeal following opposition | 28.06.2006 | Appeal received No. T1009/06 | 04.09.2006 | Statement of grounds filed | 28.11.2008 | Result of appeal procedure: revocation of the patent | 28.11.2008 | Date of oral proceedings | 12.12.2008 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 29.07.1994 | Renewal fee patent year 03 | 22.11.1995 | Renewal fee patent year 04 | 11.12.1996 | Renewal fee patent year 05 | 12.12.1997 | Renewal fee patent year 06 | 11.12.1998 | Renewal fee patent year 07 | 09.12.1999 | Renewal fee patent year 08 | Lapses during opposition Tooltip | AT | 31.12.2007 | BE | 31.12.2007 | CH | 31.12.2007 | FR | 31.12.2007 | GB | 31.12.2007 | IT | 31.12.2007 | LI | 31.12.2007 | SE | 01.01.2008 | DK | 02.01.2008 | ES | 02.01.2008 | NL | 01.07.2008 | [2010/05] |
Former [2009/30] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
FR | 31.12.2007 | ||
GB | 31.12.2007 | ||
LI | 31.12.2007 | ||
SE | 01.01.2008 | ||
DK | 02.01.2008 | ||
ES | 02.01.2008 | ||
NL | 01.07.2008 | ||
Former [2009/20] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
GB | 31.12.2007 | ||
LI | 31.12.2007 | ||
SE | 01.01.2008 | ||
DK | 02.01.2008 | ||
ES | 02.01.2008 | ||
NL | 01.07.2008 | ||
Former [2009/08] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
GB | 31.12.2007 | ||
LI | 31.12.2007 | ||
SE | 01.01.2008 | ||
DK | 02.01.2008 | ||
NL | 01.07.2008 | ||
Former [2009/07] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
GB | 31.12.2007 | ||
LI | 31.12.2007 | ||
SE | 01.01.2008 | ||
NL | 01.07.2008 | ||
Former [2009/03] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
GB | 31.12.2007 | ||
LI | 31.12.2007 | ||
NL | 01.07.2008 | ||
Former [2009/01] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
LI | 31.12.2007 | ||
NL | 01.07.2008 | ||
Former [2008/48] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
CH | 31.12.2007 | ||
LI | 31.12.2007 | ||
Former [2008/43] | AT | 31.12.2007 | |
BE | 31.12.2007 | ||
Former [2008/39] | AT | 31.12.2007 | Documents cited: | Search | [X]EP0359347 (NEORX CORP [US]) [X] 1-10 * page 4, line 47 - line 52 * * page 10, line 40 - page 11, line 14 * * claims 5,13 *; | [PX]WO9213572 (DIATECH INC [US]) [PX] 1-10 * page 5, line 34; example - * * claims 6,7 *; | [X]EP0250013 (MALLINCKRODT INC [US]) [X] 1,3,5,7,10 * example -; claim - *; | [X]EP0210684 (MALLINCKRODT INC [US]) [X] 1,3,5,7,10 * example -; claim - *; | [X]EP0196669 (DU PONT [US]) [X] 1,3,5,7,10 * example -; claim - *; | [X]WO9101144 (SANDOZ AG [AT], et al) [X] 1,3,5,7,10 * examples 8-10 *; | [X]WO9117173 (CYTOGEN CORP [US]) [X] 1,3,5,7,10 * example 8 *; | [PX] ZAMORA P O ET AL, "DIRECT TECHNETIUM-99M LABELING OF A PLATELET-BINDING LAMININ PEPTIDE", 39TH ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, LOS ANGELES, CALIFORNIA, USA, JUNE 9-12, 1992. & J NUCL MED, VOL. 33, NO. 5 (SUPPL.). 1992. PAGES 1029-1030, ABSTRACT 878, (199205), vol. 33, no. 5, pages 1031 - 1032, XP002998687 [PX] 1-10 * abstract * | [PX] M. NAKAYAMA ET AL., "DIRECT Tc-99m LABELING OF ANTIBODY WITH MACROMOLECULAR Sn(II) COMPLEXES", 39TH ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, LOS ANGELES, CALIFORNIA, USA, JUNE 9-12, 1992. & J NUCL MED, VOL. 33, NO. 5 (SUPPL.). 1992, PAGES 1029-1030, ABSTRACT 869, (199205), vol. 33, no. 5, pages 1029 - 1030, XP002998688 [PX] 1,8-10 * abstract * | [X] ZAMORA P O ET AL, "A SECOND Tc-99m BINDING SITE IN IgG IS RELATED TO HISTIDINE GROUPS", 39TH ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, LOS ANGELES, CALIFORNIA, USA, JUNE 9-12, 1992. & J NUCL MED, VOL. 33, NO. 5 (SUPPL.), 1992, PAGES 1029-1030, ABSTRACT 868, (199205), vol. 33, no. 5, page 1029, XP002998689 [X] 1-10 * abstract * | [Y] LIOTTA LA ET AL, "LAMININ RECEPTORS ON HUMAN BREAST CARCINOMA: ROLE IN INVASION OF THE EXTRACELLULAR MATRIX", UNDERSTANDING BREAST CANCER: CLINICAL AND LABORATORY CONCEPTS. RICH MA, HAGER JC, FURMANSKI P, EDS. NEW YORK, MARCEL DEKKER, INC., PAGES 87-96, 1983., pages 87 - 97, XP001202194 [Y] 1-10 * page 95 - page 96 * | [Y] SANDROCK D ET AL, "KINETICS OF IV-INJECTED 131I-LABELED LAMININ-C1 FRAGMENT IN NORMAL AND TUMOR-BEARING NUDE MICE (MEETING ABSTRACT) (abstract 390)", PROC ANNU MEET AM ASSOC CANCER RES 9, (198903), vol. 30, page 99, XP008067728 [Y] 1-10 * abstract * | [T] ZAMORA P O ET AL, "BIOLOGICAL DISTRIBUTION OF TECHNETIUM-99M LABELED YIGSR AND IKVAV LAMININ PEPTIDES IN RODENTS TECHNETIUM-99M IKVAV PEPTIDE LOCALIZES TO THE LUNG.", BIOCHIM BIOPHYS ACTA, (1993), vol. 1182, no. 2, pages 197 - 204, XP003000073 [T] 1-10 * Methods and Materials * * Discussion * DOI: http://dx.doi.org/10.1016/0925-4439(93)90141-M | [T] ZAMORA P O ET AL, "LUNG UPTAKE OF TECHNETIUM-99M LAMININ PEPTIDE PA22-2 IS DECREASED IN EMPHYSEMA AND INCREASED IN TUMORED LUNG", 40TH ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, TORONTO, ONTARIO, CANADA, JUNE 8-11, 1993.;& J NUCL MED,, VOL. 34, NO. 5 SUPPL., PAGE(S) 244P, 1993., page 244P, XP002998690 [T] 1-10 * No. 1133 * | [T] WANG G-J ET AL, "A Tc-99m labeled laminin derived peptide, Tc-99m-YIGSR for thrombus specific imaging.", 41ST ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, ORLANDO, FLORIDA, USA, JUNE 5-8, 1994.;& JOURNAL OF NUCLEAR MEDICINE 35, NO. 5 SUPPL., PAGE(S) 106P, 1994., (19940608), page 106P, XP002998691 [T] 1-10 * No. 420 * | [PY] M.V. PIMM ET AL, "111-In labelling of a branched polypeptide drug carrier with a poly(L-lysine) backbone", INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, NL, (19920112), vol. 79, pages 77 - 80, XP000431687 [PY] 1-10 * the whole document * DOI: http://dx.doi.org/10.1016/0378-5173(92)90096-K | International search | [X]CA2016235 | [X]WO9015818 | [X]WO8910760 | [A]GB2225579 | [X]WO9117173 | [X]WO8807382 | [XP]US5128119 | [AP]US5116596 | [Y]US4917878 | [X] 7th International Symposium on Radiopharmacology, Abstracts, (1991) COX et al., "Technetium Labelled Somato statin a Potential Agent for In Vivo Tumor Localization", p. 16 | [Y] Immunology (1991), Volume 72, THOMPSON et al., "Identification of an Amino Acid Sequence in the Iamminan A Chain Mediating Mask Cell Attachment and Spreading", pp. 144-149 | Examination | US5102990 | US5277893 | US5277892 |